Growth Metrics

RxSight (RXST) EBT Margin (2020 - 2026)

RxSight posted quarterly EBT Margin of 51.4% for Q1 2026, down 2983.0% year-on-year from 1.78% in Q1 2025, and down 83.22% on a QoQ basis from 28.05% in Q4 2025.

RxSight (RXST) has 7 years of EBT Margin data on file, last reported at 51.4% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 2983.0% year-over-year to 51.4%; the trailing twelve-month figure through Mar 2026 stood at 36.54% (down 3716.0% YoY), and the FY2025 full-year result was 28.91%, down 2891.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 51.4%, down from 28.05% in the prior quarter.
  • Across five years, EBT Margin topped out at 317.91% in Q4 2022 and bottomed at 196.73% in Q1 2022.
  • The 5-year median for EBT Margin is 32.32% (2025), against an average of 23.54%.
  • The widest annual swing landed in 2022, when EBT Margin surged 50478 bps; it then tumbled 18007 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 317.91% in 2022, then slumped by 57 bps to 137.84% in 2023, then sank by 61 bps to 53.41% in 2024, then tumbled by 153 bps to 28.05% in 2025, then tumbled by 83 bps to 51.4% in 2026.
  • The last three EBT Margin figures came in at 51.4% (Q1 2026), 28.05% (Q4 2025), and 32.32% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 RxSight 215.82 Mn -2.06 Mn 23.50 Mn -51.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.40%
Dec 31, 2025 -28.05%
Sep 30, 2025 -32.32%
Jun 30, 2025 -34.94%
Mar 31, 2025 -21.56%
Dec 31, 2024 53.41%
Sep 30, 2024 -17.91%
Jun 30, 2024 -17.38%
Mar 31, 2024 -30.80%
Dec 31, 2023 137.84%
Sep 30, 2023 -55.87%
Jun 30, 2023 -66.21%
Mar 31, 2023 -75.54%
Dec 31, 2022 317.91%
Sep 30, 2022 -133.32%
Jun 30, 2022 -147.29%
Mar 31, 2022 -196.73%
Dec 31, 2021 -186.87%
Sep 30, 2021 -219.10%
Jun 30, 2021 -275.15%
Mar 31, 2021 -195.12%
Dec 31, 2020 -278.63%
Sep 30, 2020 735.54%
Jun 30, 2020 -474.58%